Uday Sampangi has been appointed as the Senior Manager – Strategic Alliance & Partnerships at Lupin Digital Health, marking a significant career milestone in his 15-year journey across pharmaceutical sales, key account management, and commercial strategy. In his new role, he will drive high-impact partnerships, strengthen strategic alliances, and contribute to the organisation’s digital healthcare growth vision. His expertise in market expansion, key account success, and cross-functional leadership positions him as a valuable asset in accelerating Lupin’s digital health initiatives.
Before this appointment, Uday served as the Regional Business Manager – Key Accounts at Cipla, leading major national and regional hospitals across Karnataka. He consistently delivered exceptional performance, including a 122% YTD achievement for FY-25, and played a critical role in influencing therapy strategies, driving brand inclusion, and building strong collaborations with leading institutions such as Manipal, Aster, Cloudnine, Apollo, Fortis, and Narayana Health. His exceptional business intelligence, planning skills, and stakeholder engagement earned him the prestigious Super Achiever Award.
Prior to Cipla, Uday worked with Novo Nordisk as an Area Sales Manager, where he spearheaded the highly successful launch of Rybelsus (Oral Semaglutide) in Karnataka. Achieving 150% of sales targets in Bangalore, he built strong alliances with Key Opinion Leaders, medical associations, and scientific bodies, contributing to long-term brand leadership. His ability to merge scientific understanding with market strategy positioned him as a high-impact leader in diabetes and chronic disease portfolios.
Uday’s earlier tenure at Boehringer Ingelheim, spanning nearly nine years, shaped his foundation in leadership, sales strategy, and team management. Rising through the ranks to become Area Sales Manager, he successfully promoted innovator therapies like Jardiance and Glyxambi, led a 15-member Karnataka team, and delivered outstanding growth including a high-performing stint managing Chennai operations. His earlier roles at Sanofi, GSK, and Ranbaxy further strengthened his pharmaceutical expertise and market acumen.
Across all his roles, Uday has demonstrated strong capabilities in forecasting, sales strategy, negotiation, people management, and business development. With deep experience across diabetes, chronic care, and critical care portfolios, he brings a proven track record of accelerating growth, driving high-value partnerships, and building strong market ecosystems. His appointment at Lupin Digital Health reflects his ability to lead strategic alliances with vision, agility, and sustained impact.